Cite
HARVARD Citation
Langley, R. et al. (2018). Efficacy and safety of guselkumab in patients with psoriasis who have an inadequate response to ustekinumab: results of the randomized, double‐blind, phase III NAVIGATE trial. British journal of dermatology. pp. 114-123. [Online].